Tang C K, Huang T P, Lian J D, Chung H M
Clin Nephrol. 1978 Jul;10(1):21-6.
Twenty patients with end-stage renal disease and a creatinine clearance of less than 5 ml/min were tre ated with oral gastrointestinal (GI) dialysis. The dialyzate contained an electrolyte solution with 180-220mmoles/l of mannitol. In fasting state in the morning the self-prepared 7 liters of dialyzate was drunk at a rate of one glass every 5 minutes for about 3 hours. Intermittent diarrhea with passage of watery fluid occurred during the whole period. After each treatment the average drop in BUN in individual patients was 11--22%, but no significant decrease in serum creatinine. With twice to thrice weekly GI dialysis uremic symptoms such as anorexia, nauseal and vomiting were usually improved with slight prolongation of life. However, treatment is usually difficult when the patient becomes oliguric or anuric, so its value in long-term management of chronic uremia is limited. Most of our patients either died or shifted to hemodialysis within a few months of institution of the therapy.
20例终末期肾病且肌酐清除率低于5ml/分钟的患者接受了口服胃肠透析治疗。透析液为含180 - 220毫摩尔/升甘露醇的电解质溶液。早晨空腹状态下,自行配制的7升透析液以每5分钟一杯的速度饮用,持续约3小时。整个过程中出现间歇性腹泻并伴有水样便排出。每次治疗后,个体患者的血尿素氮平均下降11% - 22%,但血清肌酐无显著下降。每周进行两到三次胃肠透析后,诸如厌食、恶心和呕吐等尿毒症症状通常会有所改善,患者寿命稍有延长。然而,当患者出现少尿或无尿时,治疗通常会变得困难,因此其在慢性尿毒症长期管理中的价值有限。我们的大多数患者在开始治疗后的几个月内要么死亡,要么转而接受血液透析。